Sensus Healthcare
SRTS
Sensus Healthcare (SRTS) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.53
- EPS estimate
- −$0.13
- EPS surprise
- −324.00%
- Revenue surprise
- −50.23%
- Revenue
- $2.3M
- Revenue estimate
- $4.6M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.13 | −$0.53 | −324.00% | $2.3M | SEC |
| Q1 2026 | May 7, 2026 | −$0.13 | −$0.16 | −28.00% | $3.4M | SEC |
| Q4 2025 | Feb 12, 2026 | −$0.07 | −$0.19 | −171.43% | $4.9M | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.10 | −$0.06 | +36.84% | $6.9M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.03 | −$0.06 | −330.77% | $7.3M | SEC |
| Q1 2025 | May 15, 2025 | $0.03 | −$0.16 | −570.59% | $8.3M | SEC |
| Q4 2024 | Feb 5, 2025 | $0.12 | $0.09 | −27.42% | $13.1M | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.01 | $0.07 | +800.00% | $8.8M | SEC |
| Q2 2024 | Aug 8, 2024 | $0.02 | $0.10 | +329.18% | $9.2M | SEC |
| Q1 2024 | May 9, 2024 | −$0.04 | $0.14 | +423.33% | $10.7M | SEC |
| Q4 2023 | Feb 8, 2024 | $0.14 | $0.26 | +82.46% | $12.6M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.02 | −$0.09 | −400.00% | $3.9M | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.08 | −$0.02 | +73.68% | $4.5M | SEC |
| Q1 2023 | May 3, 2023 | $0.13 | −$0.12 | −196.00% | $3.4M | SEC |
| Q4 2022 | Feb 9, 2023 | $0.23 | $0.17 | −26.09% | $13.1M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.13 | $0.11 | −12.70% | $9.0M | — |
| Q2 2022 | Aug 4, 2022 | $0.13 | $0.21 | +59.09% | $12.1M | — |
| Q1 2022 | May 5, 2022 | $0.04 | $0.97 | +2140.18% | $10.3M | — |
| Q4 2021 | Feb 10, 2022 | $0.16 | $0.32 | +95.12% | $13.0M | — |
| Q3 2021 | Nov 4, 2021 | −$0.02 | $0.01 | +159.88% | $5.5M | — |
Quarterly revenue
Frequently asked questions
When did Sensus Healthcare (SRTS) last report earnings?
Sensus Healthcare last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did SRTS beat earnings estimates?
No. Sensus Healthcare reported EPS of −$0.53 for Q2 2026 against a −$0.13 estimate — a 324.00% miss.
How much revenue did SRTS report last quarter?
Sensus Healthcare reported $2.3M in revenue for Q2 2026, against a consensus estimate of $4.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.